ABC | Volume 111, Nº5, November 2018

Original Article Rattanawong et al PR interval and chronic resynchronization therapy Arq Bras Cardiol. 2018; 111(5):710-719 1. Epstein AE, Di Marco JP, Ellenbogen KA, Estes NA3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/ AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-75. 2. FriedmanDJ, BaoH, Spatz ES, Curtis JP, Daubert JP, Al-Khalib SM. Association between a prolonged PR interval and outcomes of cardiac resynchronization therapy: a report from theNational Cardiovascular Data Registry. Circulation, 2016;134(21):1617-28. 3. Waggoner AD, Kalathivetil S, Spence KE, D'avila Roman VG, de las Fuentes L. Interatrial conduction time and left atrial function in patients with left ventricular systolic dysfunction: effects of cardiac resynchronization therapy. J Am Soc Echocardiogr. 2009;22(5):472-7. 4. Januszkiewicz L, Vegh E, Borgquist R, Bose A, Sharm A, Orencole M, et al. Prognostic implication of baseline PR interval in cardiac resynchronization therapy recipients. Heart Rhythm. 2015;12(11):2256-62. 5. Pires, LA,AbrahamWT, Young JB, Johnson KM, MIRACLE-ICD Invesigators. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Am Heart J. 2006;151(4):837-43. 6. Gervais R, Leclercg C, Shankar A, Jacobs S,Eiskjaer H, Johannessen A. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail, 2009;11(7):699-705. 7. Lee YH, Wu JH, Asirvatham SJ, Del Carppio Munoz F, Webster T, Brooke KL,etal. Effectsofatrioventricularconductiondelayontheoutcomeofcardiac resynchronization therapy. J Electrocardiol. 2014;47(6):930-5. 8. Olshansky B, Day ID, Sullivan RM, Yong P, Galle E, Steinberg JC. Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial. Heart Rhythm. 2012;9(1):34-9. 9. Kutyifa V, Stockburger M, Daubert JP, Holmgrvist F, Olshansky B, Schuger C, et al. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial- Cardiac Resynchronization Therapy Substudy. Circ ArrhythmElectrophysiol, 2014;7(4):645-51. 10. Joshi NP, Stopper MM, Beshai JF, Pavri BB. Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial. J Interv Card Electrophysiol. 2015; 43(2):145-9. 11. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. 12. Der Simonian R,Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. 13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. 14. Sterneb JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-55. 15. RickardJ,KarimM,BaranowskiB,CantillonD,SpraggD,TangWH,etal. Effect of PR interval prolongation on long-termoutcomes in patients with left bundle branch block vs non-left bundle branch block morphologies undergoing cardiac resynchronization therapy. Heart Rhythm.2017;14(10):1523-8. 16. Kronborg MB, Nielsen JC, Mortensen PT. Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy. Europace. 2010; 12(2):216-22. 17. Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Lerry D, et al. Long-term outcomes in individuals with prolonged PR interval or first- degree atrioventricular block. JAMA. 2009;301(24):2571-7. 18. Schnittger L, Appleton CP, Hatle LK, Popp RL. Diastolic mitral and tricuspid regurgitation by Doppler echocardiography in patients with atrioventricular block: new insight into themechanismof atrioventricular valve closure. J Am Coll Cardiol. 1998;11(1):83-8. 19. Maloney J, Khoury D, Simmons T, Willkoff B, Morant V, Trohman R. Effect of atrioventricular synchrony on stroke volume during ventricular tachycardia in man. AmHeart J. 1992;123(6):1561-8. 20. AuricchioA,Ding J,Spinelli JC,KramerAP,SaloRW,HoerschW,etal. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol. 2002;39(7):1163-9. 21. Magnani JW, Wang N, Nelson KP, Connelly S, Deo R, Rodondi N, et al. Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol. 2013;6(1):84-90. 22. MarcusGM. ThePR intervalandcardiacresynchronizationtherapyoutcomes: considering confounding, mediation, and effect modification. Heart Rhythm. 2012;9(1):40-1. 23. Yancy CW, JessupM, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart AssociationTaskForceonpracticeguidelines. Circulation.2013;128(16):1810-52. 24. Rickard, J, Michtalik H, Sharma R, Berger Z, Iyoha E, Green AR, et al. Predictors of response to cardiac resynchronization therapy: A systematic review. Int J Cardiol. 2016; 225:345-52. References 717